内分泌腺来源的血管内皮细胞生长因子在人胰腺癌组织中的表达及临床意义

任丽楠; 郭晓钟; 邹德莉

内分泌腺来源的血管内皮细胞生长因子在人胰腺癌组织中的表达及临床意义

沈阳军区总医院消化内科

基金项目:

国家自然科学基金(81071982)；辽宁省博士科研启动基金(20111094)；

详细信息

中图分类号: R735.9
计量
- 文章访问数: 3334
- HTML全文浏览量: 25
- PDF下载量: 642
- 被引次数: 0
出版历程
- 出版日期: 2012-08-20

EG-VEGF expression and significance in pancreatic carcinoma

Research funding:

摘要

摘要: 目的探讨内分泌腺来源的血管内皮细胞生长因子（EG-VEGF）在人胰腺癌组织中的表达及临床意义。方法应用免疫组化技术检测EG-VEGF在60例胰腺癌组织和10例正常胰腺组织中的表达情况,并分析其与临床病理因素之间的关系。结果EG-VEGF在60例胰腺癌组织中的阳性表达率为95%（57/60）,而在10例正常胰腺组织中的阳性表达率为10%（1/10）,两者间差异有统计学意义（P<0.05）。EG-VEGF的表达与胰腺癌的临床病理分期以及淋巴结转移呈正相关（P<0.05）,而与性别、年龄、病理分级无明显相关性（P>0.05）。结论 EG-VEGF在胰腺癌的发生发展过程中起着重要作用,可作为判断胰腺癌预后的有用指标。
- 胰腺肿瘤 /
- 血管内皮生长因子 /
- 病理学,临床
Abstract: Objective To investigate the expression of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in pancreatic carcinoma and investigate its relation to clinicopathologic features and prognosis of the disease. Methods Immunohistochemical staining tissue microarray was used to detect expression of EG-VEGF in 60 cases of pancreatic carcinoma and 10 cases of normal pancreatic tissues.The clinical significance of EG-VEGF expression in pancreatic cancer was analyzed by the Cochran-Mantel-Haenszel or Fisher's exact test statistical methods. Results The positive rate of EG-VEGF was significantly higher in pancreatic carcinomas (95%, 57/60) .than in normal pancreas tissues (10%, 1/10) (P<0.05) .EG-VEGF protein expression was closely correlated with TNM stage and lymph node metastasis (both P<0.05) . Conclusion High expression of EG-VEGF plays a considerable role in development of pancreatic carcinoma.EG-VEGF may be a useful prognostic marker for pancreatic cancer.
- pancreatic neoplasms /
- vascular endothelial growth factor /
- endocrine-gland-derived

HTML全文

参考文献(16)

[1]Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2008[J].CA Cancer J Clin, 2008, 58 (2) :71-96.

[2]Panker SL, Tong T, Bolden S, et al.Cancer Statistics[J].CA Cancer J Clin, 1997, 47 (1) :5-27.

[3]Witrekind C, Oberschmid B.TNM classification of malignanttumors 2010:general aspects and amendments in thegeneralsection[J].Pathologe, 2010, 31:333-334, 336-338.

[4]LeCouter J, Kowalski J, Foster J, et al.Identification of anangiogenic mitogen selective for endocrine gland endothelium[J].Nature, 2001, 412 (6850) :877-884.

[5] Brouillet S, Hoffmann P, Chauvet S, et al.Revisiting the roleof HCG:new regulation of the angiogenic factor EG-VEGFand its receptors[J].Cell Mol Life Sci, 2012, 69 (9) :1537-1550.

[6]Ngan ES, Tam PK.Prokineticin-signaling pathway[J].IntJ Biochem Cell Biol, 2008, 40 (9) :1679-1684.

[7]Samson M, Peale FV Jr, Frantz G, et al.Human endocrinegland-derived vascular endothelial growth factor:expressionearly in development and in Leydig cell tumors suggests rolesin normal and pathological testis angiogenesis[J].J Clin En-docrinol Metab, 2004, 89 (8) :4078-4088.

[8]Goi T, Fujioka M, Satoh Y, et al.Angiogenesis and tumorproliferation etastasis of human colorectal cancer cell lineSW620 transfected with endocrine glands-derived-vascu-lar endothelial growth factor, as a new angiogenic factor[J].Cancer Res, 2004, 64 (6) :1906-1910.

[9]Pasquali D, Rossi V, Staibano S, et al.The endocrine-gland–derived vascular endothelial growth factor (EG-VEGF) /prokineticin 1 and 2 and receptor expression in human prostate:up-regulation of EG-VEGF/prokineticin 1 with malignancy[J].Endocrinology, 2006, 147 (9) :4245-4251.

[10]Zhang L, Yang N, Conejo-Garcia JR, et al.Expression ofendocrine gland-derived vascular endothelial growth factorin ovarian carcinoma[J].Clin Cancer Res, 2003, 9 (1) :264-272.

[11]Ren LN, Li QF, Xiao FJ, et al.Endocrine glands-derivedvasular endothelial growth facter protects pancreatic cancercells from apoptosis via upregulation of the myeloid cell leu-kemia-1 protein[J].Biochem Biophys Res Commun, 2009, 386 (1) :35-39.

[12] 任丽楠, 郭晓钟, 邹德莉, 等.EG-VEGF在胰腺癌细胞中抗凋亡的信号转导机制研究[J].中华胰腺病杂志, 2011, 11 (3) :194-196.

[13]Pasquali D, Santoro A, Bufo P, et al.Upregulation of endo-crine gland-derived vascular endothelial growth factor in pa-pillary thyroid cancers displaying infiltrative patterns, lymphnode metastases, and BRAF mutation[J].Thyroid, 2011, 21 (4) :391-399.

[14]Li QF, Zhu HY, Yang YF, et al.Prokineticin-1/endocrinegland-derived vascular endothelial growth factor is a survivalfactor for human multiple myeloma cells[J].Leuk Lympho-ma, 2010, 51 (10) :1902-1912.

[15]Ngan ES, Sit FY, Lee K, et al.Implications of endocrinegland-derived vascular endothelial growth factor/prokineti-cin-1 signaling in human neuroblastoma progression[J].Clin Cancer Res, 2007, 13 (3) :868-875.

[16]Morales A, Morimoto S, Díaz L, et al.Endocrine gland-de-rived vascular endothelial growth factor in rat pancreas:ge-netic expression and testosterone regulation[J].J Endocri-nol, 2008, 197 (2) :309-314.

施引文献

资源附件(0)

访问统计